Search | IOVS | ARVO Journals

Showing 1 – 20 of 22

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract July 2018

Vascular endothelial growth factor (VEGF) mediates electroretinogram (ERG) dysfunction in mice through plasma kallikrein and nitric oxide

Allen C Clermont; Fabricio Simao; Nivetha Murugesan; Paul Huang; Lloyd P Aiello; Edward P Feener

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):3463. doi:

ARVO Annual Meeting Abstract July 2018

A novel oral plasma kallikrein (PKal) inhibitor KV123833 blocks VEGF-mediated retinal vascular hyperpermeability in a murine model of retinal edema

Nivetha Murugesan; Allen C Clermont; Louise J Rushbrooke; Peter A Robson; Robrecht Thoonen; Stephen J Pethen; Sally L Hampton; Edward P Feener

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):3464. doi:

ARVO Annual Meeting Abstract June 2017

Effects of Vascular endothelial growth factor (VEGF) on electroretinogram (ERG) amplitude in rats are mediated by bradykinin.

Allen C Clermont; Nivetha Murugesan; Tuna Ustunkaya; Brianna Mastromarino; Lloyd P Aiello; Edward P Feener

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):5347. doi:

ARVO Annual Meeting Abstract September 2016

Increased FXII activity in vitreous of patients with Diabetic Macular Edema (DME) and in animal models of VEGF- and bradykinin-induced retinal edema

Tuna Ustunkaya; Nivetha Murugesan; Allen C Clermont; Edward P Feener

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):4183. doi:

ARVO Annual Meeting Abstract September 2016

Title: Complement component 3 (C3) is increased in vitreous in diabetic macular edema and is required for bradykinin (BK)-induced retinal edema.

Nivetha Murugesan; Allen C Clermont; Takeshi Kita; Edward P Feener

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12) doi:

ARVO Annual Meeting Abstract September 2016

Vascular endothelial growth factor (VEGF) and bradykinin induce increased electroretinogram amplitude and decreased visual acuity.

Allen C Clermont; Nivetha Murugesan; Cheng-mao Lin; Sarah R Sheskey; David A Antonetti; Edward P Feener

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12) doi:

Retina May 2016

Plasma Kallikrein Mediates Vascular Endothelial Growth Factor–Induced Retinal Dysfunction and Thickening

PDF

Allen Clermont; Nivetha Murugesan; Qunfang Zhou; Takeshi Kita; Peter A. Robson; Louise J. Rushbrooke; D. Michael Evans; Lloyd Paul Aiello; Edward P. Feener
TAGS: vascular endothelial growth factor a, edema, plasma kallikrein, mice, retina, intravitreal injections
Invest. Ophthalmol. Vis. Sci.. 2016; 57(6):2390-2399. doi: 10.1167/iovs.15-18272

Includes: Supplemental Content

Biochemistry and Molecular Biology November 2015

Proteomic Analysis of Embryonic and Young Human Vitreous

PDF

Kenneth M. P. Yee; Edward P. Feener; Michele Madigan; Nicholas J. Jackson; Ben-Bo Gao; Fred N. Ross-Cisneros; Jan Provis; Lloyd Paul Aiello; Alfredo A. Sadun; J. Sebag
TAGS: immunohistochemistry, embryo, fetus, vitreous body, proteins, proteomics
Invest. Ophthalmol. Vis. Sci.. 2015; 56(12):7036-7042. doi: 10.1167/iovs.15-16809

Includes: Supplemental Content

ARVO Annual Meeting Abstract June 2015

Proteomic characterization of retinal edema in rats

Nivetha Murugesan; Allen C Clermont; LeiLei Sun; Edward P Feener

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):4693. doi:

ARVO Annual Meeting Abstract June 2015

Vascular endothelial growth factor (VEGF)- and the kallikrein kinin system (KKS)- induced neuronal dysfunction in a rodent model of retinal edema.

Allen C Clermont; Nivetha Murugesan; Edward P Feener

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):5487. doi:

ARVO Annual Meeting Abstract April 2014

Plasma kallikrein (PKal) deficiency ameliorates the effects of vascular endothelial growth factor (VEGF) on retinal hyperpermeability and edema.

Allen C Clermont; Qunfang Zhou; Nivetha Murugesan; Ward Fickweiler; Edward P Feener

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):594. doi:

ARVO Annual Meeting Abstract April 2014

Role of Akt in VEGF-, bradykinin-, and diabetes-induced retinal dysfunction and edema

Ward Fickweiler; Allen C Clermont; Nivetha Murugesan; Edward P Feener

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):2256. doi:

ARVO Annual Meeting Abstract June 2013

Correlation of the Aqueous and Vitreous Proteomes in Diabetic Eye Disease

Nour Maya Haddad; Jennifer Sun; Michael Molla; Paul Arrigg; Sabera Shah; Deborah Schlossman; Timothy Murtha; Edward Feener; Lloyd Aiello

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):1128. doi:

ARVO Annual Meeting Abstract June 2013

Plasma Kallikrein Deficiency is protective against diabetes induced retinal vascular dysfunction

Allen Clermont; Qunfang Zhou; Takeshi Kita; Jia Liu; Lloyd Aiello; Edward Feener

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):1137. doi:

ARVO Annual Meeting Abstract June 2013

Imaging Functional Hyperemia in Response to Flicker Stimulus in the Rat Retina Using Ultrahigh-Speed Spectral / Fourier Domain OCT

WooJhon Choi; Allen Clermont; Edward Feener; David Boas; James Fujimoto

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):4894. doi:

ARVO Annual Meeting Abstract June 2013

Effects of Plasma Kallikrein on the neuroretina in diabetic rats

GONGXIONG WU; Edward Feener

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):4127. doi:

Physiology and Pharmacology February 2013

Intraocular Hemorrhage Causes Retinal Vascular Dysfunction via Plasma Kallikrein

PDF

Jia Liu; Allen C. Clermont; Ben-Bo Gao; Edward P. Feener
TAGS: hemorrhage, collagen, collagenase, dyes, evans blue stain, eye hemorrhage, fluorescein, leukostasis, mechlorethamine, pericytes, plasma kallikrein, retinal hemorrhage, vitreous body, bradykinin, eye, proteins, rats, retina, acridine orange, pathophysiology, proteolysis, intravitreal injections
Invest. Ophthalmol. Vis. Sci.. 2013; 54(2):1086-1094. doi: 10.1167/iovs.12-10537

ARVO Annual Meeting Abstract March 2012

Identification of a VEGF-independent and Plasma Kallikrein-Kinin-dependent pathway of retinal vascular permeability in Diabetic Macular Edema

Takeshi Kita; Allen C. Clermont; Kimihiko Fujisawa; Tatsuro Ishibashi; Lloyd P. Aiello; Edward P. Feener

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):2431. doi:

ARVO Annual Meeting Abstract March 2012

Analysis of Total Retinal Blood Flow in Normal and Diabetic Rats with Ultrahigh-Speed Spectral / Fourier Domain OCT

Woo Jhon Choi; Bernhard Baumann; Allen C. Clermont; Edward P. Feener; Jonathan J. Liu; Alison M. Hayward; Jay S. Duker; James G. Fujimoto

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):4987. doi:

ARVO Annual Meeting Abstract April 2011

Heterogeneity of the Vitreous Proteome in Diabetic Macular Edema Correlates with Levels of Plasma Kallikrein and VEGF

Takeshi Kita; Allen C. Clermont; Kimihiko Fujisawa; Tatsuro Ishibashi; Lloyd P. Aiello; Edward P. Feener

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):3569. doi:

1 2

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Vascular endothelial growth factor (VEGF) mediates electroretinogram (ERG) dysfunction in mice through plasma kallikrein and nitric oxide

A novel oral plasma kallikrein (PKal) inhibitor KV123833 blocks VEGF-mediated retinal vascular hyperpermeability in a murine model of retinal edema

Effects of Vascular endothelial growth factor (VEGF) on electroretinogram (ERG) amplitude in rats are mediated by bradykinin.

Increased FXII activity in vitreous of patients with Diabetic Macular Edema (DME) and in animal models of VEGF- and bradykinin-induced retinal edema

Title: Complement component 3 (C3) is increased in vitreous in diabetic macular edema and is required for bradykinin (BK)-induced retinal edema.

Vascular endothelial growth factor (VEGF) and bradykinin induce increased electroretinogram amplitude and decreased visual acuity.

Plasma Kallikrein Mediates Vascular Endothelial Growth Factor–Induced Retinal Dysfunction and Thickening

Proteomic Analysis of Embryonic and Young Human Vitreous

Proteomic characterization of retinal edema in rats

Vascular endothelial growth factor (VEGF)- and the kallikrein kinin system (KKS)- induced neuronal dysfunction in a rodent model of retinal edema.

Plasma kallikrein (PKal) deficiency ameliorates the effects of vascular endothelial growth factor (VEGF) on retinal hyperpermeability and edema.

Role of Akt in VEGF-, bradykinin-, and diabetes-induced retinal dysfunction and edema

Correlation of the Aqueous and Vitreous Proteomes in Diabetic Eye Disease

Plasma Kallikrein Deficiency is protective against diabetes induced retinal vascular dysfunction

Imaging Functional Hyperemia in Response to Flicker Stimulus in the Rat Retina Using Ultrahigh-Speed Spectral / Fourier Domain OCT

Effects of Plasma Kallikrein on the neuroretina in diabetic rats

Intraocular Hemorrhage Causes Retinal Vascular Dysfunction via Plasma Kallikrein

Identification of a VEGF-independent and Plasma Kallikrein-Kinin-dependent pathway of retinal vascular permeability in Diabetic Macular Edema

Analysis of Total Retinal Blood Flow in Normal and Diabetic Rats with Ultrahigh-Speed Spectral / Fourier Domain OCT

Heterogeneity of the Vitreous Proteome in Diabetic Macular Edema Correlates with Levels of Plasma Kallikrein and VEGF

To View More...

You must be signed into an individual account to use this feature.